Johan W Lagerberg1,2, Herbert Korsten1, Pieter F Van Der Meer1,2, Dirk De Korte1,2. 1. Sanquin Blood Bank, Department Product and Process Development, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. 2. Sanquin Research, Department Blood Cell Research and Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Abstract
BACKGROUND: In Europe, red cell concentrates (RCC) are usually stored in SAGM (saline-adenine-glucose-mannitol). During storage, in vitro red cell quality declines, including lowered energy status and increased cell lysis. Recently, several additive solutions (ASs), designed to diminish the decline in in vitro quality during storage, have been developed. These new solutions have mainly been developed to better maintain red blood cell (RBC) 2,3-biphosphoglycerate (2,3 BPG) levels and energy status during storage. High levels of 2,3 BPG allow for better oxygen release while high energy status is necessary for function and survival of RBC in vivo. In a paired study design, RBC ASs were compared for their ability to provide improved in vitro quality during hypothermic storage. MATERIALS AND METHODS: For each experiment, 5 whole blood units held overnight were pooled and split. The whole blood units were processed according to the buffy coat method. RBCs were resuspended in either SAGM, PAGGSM, PAG3M, E-Sol 5 or AS-7 and leucoreduced by filtration. RCCs were stored for eight weeks at 2-6 °C and sampled weekly for analysis of in vitro quality parameters. RESULTS: Red cell concentrates stored in PAG3M, E-Sol 5 and AS-7 showed significantly higher lactate production and higher levels of intracellular adenosine triphosphate (ATP) and total adenylate. 2,3 BPG levels rapidly declined during storage in SAGM and PAGGSM. The decline in 2,3 BPG was inhibited during storage in E-Sol 5 and AS-7, while in PAG3M, 2,3 BPG level increased above the initial level till day 35 and remained detectable till day 56. Haemolysis was comparable for all ASs until day 35, upon prolonged storage, haemolysis in SAGM was higher than with the other ASs. As compared to SAGM, storage in PAGGSM, PAG3M, E-Sol 5 and AS-7 better maintained morphological properties. DISCUSSION: Storage of RBCs in the new generation ASs yield RBCs with more stable metabolite levels and improved overall quality during storage as compared with RBCs stored in SAGM.
BACKGROUND: In Europe, red cell concentrates (RCC) are usually stored in SAGM (saline-adenine-glucose-mannitol). During storage, in vitro red cell quality declines, including lowered energy status and increased cell lysis. Recently, several additive solutions (ASs), designed to diminish the decline in in vitro quality during storage, have been developed. These new solutions have mainly been developed to better maintain red blood cell (RBC) 2,3-biphosphoglycerate (2,3 BPG) levels and energy status during storage. High levels of 2,3 BPG allow for better oxygen release while high energy status is necessary for function and survival of RBC in vivo. In a paired study design, RBC ASs were compared for their ability to provide improved in vitro quality during hypothermic storage. MATERIALS AND METHODS: For each experiment, 5 whole blood units held overnight were pooled and split. The whole blood units were processed according to the buffy coat method. RBCs were resuspended in either SAGM, PAGGSM, PAG3M, E-Sol 5 or AS-7 and leucoreduced by filtration. RCCs were stored for eight weeks at 2-6 °C and sampled weekly for analysis of in vitro quality parameters. RESULTS: Red cell concentrates stored in PAG3M, E-Sol 5 and AS-7 showed significantly higher lactate production and higher levels of intracellular adenosine triphosphate (ATP) and total adenylate. 2,3 BPG levels rapidly declined during storage in SAGM and PAGGSM. The decline in 2,3 BPG was inhibited during storage in E-Sol 5 and AS-7, while in PAG3M, 2,3 BPG level increased above the initial level till day 35 and remained detectable till day 56. Haemolysis was comparable for all ASs until day 35, upon prolonged storage, haemolysis in SAGM was higher than with the other ASs. As compared to SAGM, storage in PAGGSM, PAG3M, E-Sol 5 and AS-7 better maintained morphological properties. DISCUSSION: Storage of RBCs in the new generation ASs yield RBCs with more stable metabolite levels and improved overall quality during storage as compared with RBCs stored in SAGM.
Authors: P F van der Meer; H W Reesink; S Panzer; J Wong; S Ismay; A Keller; J Pink; C Buchta; V Compernolle; S Wendel; S Biagini; P Scuracchio; L Thibault; M Germain; J Georgsen; S Bégué; D Dernis; E Raspollini; S Villa; P Rebulla; M Takanashi; D de Korte; M Lozano; J Cid; H Gulliksson; R Cardigan; C Tooke; M K Fung; N L C Luban; R Vassallo; R Benjamin Journal: Vox Sang Date: 2013-12-12 Impact factor: 2.144
Authors: Jose A Cancelas; Larry J Dumont; Lou A Maes; Neeta Rugg; Louise Herschel; Pamela H Whitley; Zbigniew M Szczepiokowski; Alan H Siegel; John R Hess; Majid Zia Journal: Transfusion Date: 2014-09-19 Impact factor: 3.157
Authors: Angelo D'Alessandro; Travis Nemkov; Marguerite Kelher; F Bernadette West; Rani K Schwindt; Anirban Banerjee; Ernest E Moore; Christopher C Silliman; Kirk C Hansen Journal: Transfusion Date: 2014-12-30 Impact factor: 3.157
Authors: Patrick Burger; Herbert Korsten; Arthur J Verhoeven; Dirk de Korte; Robin van Bruggen Journal: Transfusion Date: 2012-01-10 Impact factor: 3.157
Authors: Angelo D'Alessandro; Julie A Reisz; Rachel Culp-Hill; Herbert Korsten; Robin van Bruggen; Dirk de Korte Journal: Transfusion Date: 2018-04-06 Impact factor: 3.157
Authors: Kelli Simms; Elisabeth Rebholz; Robert M Mayberry; Swati Basu; Andreas Perlegas; Martin Guthold; Daniel B Kim-Shapiro; Elaheh Rahbar Journal: Ann Biomed Eng Date: 2019-03-27 Impact factor: 3.934
Authors: Michał Bubiński; Agnieszka Gronowska; Paweł Szykuła; Agnieszka Woźniak; Aleksandra Rodacka; Scott Santi; Marcia Cardoso; Elżbieta Lachert Journal: Blood Transfus Date: 2022-02-01 Impact factor: 5.752
Authors: Sanne de Bruin; Anna-Linda Peters; Marije Wijnberge; Floor E H P van Baarle; Amira H A AbdelRahman; Christie Vermeulen; Boukje M Beuger; Julie A Reisz; Angelo D'Alessandro; Alexander P J Vlaar; Dirk de Korte; Robin van Bruggen Journal: Blood Adv Date: 2022-07-12
Authors: Anna Zimna; Magdalena Kaczmarska; Ewa Szczesny-Malysiak; Aleksandra Wajda; Katarzyna Bulat; Fatih Celal Alcicek; Malgorzata Zygmunt; Tomasz Sacha; Katarzyna Maria Marzec Journal: Int J Mol Sci Date: 2021-03-12 Impact factor: 5.923